See also this year's filing and all EDGAR filings for this company.
PDF Report 0001811764_2022_POINT_Biopharma_Global_Inc.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Turning Point Therapeutics Inc.', 'shared_tokens': {'point'}}]} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001811764')"} |
Graph
Absolute values for 0001811764, POINT Biopharma Global Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 243,846,556 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 19,412,086 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 7,979,964 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 65,592 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,006,438 |
| 9 | ResearchAndDevelopmentExpense | 33,505,392 |
| 10 | remainder_Expenses | 305,658 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -84,993 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 263,258,642 |
| 1 | Liabilities | 8,045,556 |
| 2 | Expenses | 45,817,488 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 255,213,086 |
| 5 | NetIncome | -45,902,481 |
| 6 | ComprehensiveNetIncome | -45,902,481 |
| 7 | BaseVar | 158,603,340 |
| 8 | EconomicCapitalRatio | 2.90 |
Edgar->Model Mapping
Feature Distribution
Change over Time
